EMEA news in brief
The European Medicines Agency (EMEA) has published guidance on genotoxicity testing and related data interpretation for pharmaceuticals manufacturing;
The European Medicines Agency (EMEA) has published guidance on genotoxicity testing and related data interpretation for pharmaceuticals manufacturing;
EMEA has released a working group report recommending ways of improving the methodology, consistency, transparency, and communication benefit-risk assessments staged by its committee for human medicinal products;
Procedural advice on appealing against EMEA decisions on orphan medicinal product designations has been published;
EMEA has also released updated rules on paying its fees;
Meanwhile, the European Commission is consulting on an update to its good manufacturing guidelines on basic requirements for active substances used as starting materials; and on the manufacture of investigational medicinal products.